PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1354342
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1354342
Global Surgical Staplers Market size is poised to record over 7.5% CAGR from 2023-2032.
The growing focus of regulatory bodies across the world on updating and strengthening the regulations governing several medical devices, such as surgical staplers will drive the industry growth. For instance, in October 2021, the U.S. FDA issued the final order as well as guidance on surgical staplers and staples to cater to internal use. The adherence to stricter quality and safety standards by manufacturers to ensure the effectiveness and safety of the staplers will also prove favorable for the product demand.
The overall surgical staplers industry is segmented based on product, technology, usability, surgery and region.
In terms of product, the circular surgical staplers market value will witness expansion through 2032 driven by their growing adoption in end-to-end anastomosis, including cervical esophagogastric anastomosis in esophagectomy. These staplers play important role in ensuring secure, leak-free anastomoses as well as closures in wide range of surgical procedures. Rising application scope in chronic and complicated surgeries, such as transanal procedures for removing and reconnecting sections of the rectum will add to the segment growth.
With respect to technology, the surgical staplers market size from the manual segment is expected to expand up to 2032 due to advantages, such as higher availability and affordability. Manual surgical staplers are widely employed in various surgical procedures for facilitating the closure of incisions, resection of tissue, and anastomosis. On account of their faster closure times, consistent results, and reduced tissue trauma, these staplers offer several advantages over traditional suturing techniques.
Regionally, Europe surgical staplers industry size is expected to observe robust growth through 2032 due to the rising frequency of chronic diseases including cancer, cardiovascular disease and diabetes. According to Macmillan Cancer Support, nearly 4 million people are likely to be diagnosed with cancer in the U.K. by 2030. The jump in the number of surgery centers and the surging preference for minimally invasive surgical techniques will also influence the regional market growth.